AzTrials
AzTrials

SleepN-SyncNCT07329283

Nighttime Synchrony of Your Nutrition and Circadian Health

A study testing Central Clock Misalignment and Peripheral Misalignment in people with Sleep and Metabolism Changes, run by University of Utah at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Sleep is an important factor for overall health. This study will see how different light exposure patterns and food intake impact a person's metabolism (how the body breaks down food) when sleeping is reduced. Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Sleep, Metabolism Changes, Circadian Rhythm
What is being tested?
Central Clock Misalignment and Peripheral Misalignment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
19 Dec 2025to 31 May 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age: 18-35 years old; equal numbers of men and women
  • Body Mass Index (BMI): 18.5-24.9 kg/m2
  • Sleep Habits: habitual self-reported average total sleep time (TST) 7-9 hours per night for prior 6 months

Who cannot join

  • Clinically diagnosed sleep disorder or apnea hypopnea index (AHI) ≥5
  • Evidence of significant organ system dysfunction or disease (e.g., heart disease, diabetes)
  • Fasting plasma glucose ≥100 mg/dL
  • Major psychiatric illness (e.g., major depressive disorder)
  • Cancer that has been in remission less than 5 years
  • History of shift-work in prior year
Show all 15Show fewer
  • Weight change >5% of body weight over prior six months
  • Currently following a weight-loss program
  • Menopause
  • Pregnant/nursing
  • Greater than 5-day variation in menstrual cycle length month-to-month
  • Currently smoking
  • Alcohol intake >14 drinks/week or >3 drinks/day.
  • Use of prescription medications (except oral contraceptives) within one month prior to or during in-lab visits.
  • Consumption of illegal drugs or >500mg per day of caffeine.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Victoria Miranda, MS contact

385-309-0551

SleepStudyParticipant@utah.edu

Grace Zimmerman, PhD contact

385-309-0551

SleepStudyParticipant@utah.edu

United States1 site, 1 recruiting
  • College of Health Research Complex - University of Utah, Salt Lake City 84112

    Salt Lake City, Utah, 84112

    Christopher Depner, PhD, 8015812275, sleepstudyparticipant@utah.edu

    Christopher Depner, PhD

    Recruiting

Other trials in United States

About this study

Official title: Nighttime Synchrony of Your Nutrition and Circadian Health: The N-Sync Study

Sleep is an important factor for overall health. This study will see how different light exposure patterns and food intake impact a person's metabolism (how the body breaks down food) when sleeping is reduced.

Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. People will complete surveys and medical tests. The study will last about 4 to 6 months.

Read the detailed description

This study is a randomized in-lab, cross-over trial. Each participant will complete all three arms in either condition order #1 (A-B-C) or order #2 (A-C-B). Each arm will consist of 5 nights of experimental sleep restriction followed by a constant routine protocol for assessment of 24-h rhythms. Sleep restriction in the three arms will occur under the following conditions: (A-control condition) Sleep Restriction with Central and Peripheral Alignment; (B) Sleep Restriction with Central Clock Misalignment; and (C) Sleep Restriction with Peripheral Misalignment. Prior to enrollment participants will complete a comprehensive medical history and clinical overnight sleep disorders screening. Baseline consists of a ~2-week ambulatory real-world monitoring segment that will occur immediately prior to each in-lab sleep restriction condition. Following the 5 days of sleep restriction in each arm, participants will complete an intravenous glucose tolerance test to analyze insulin sensitivity, prior to completing the constant routine.

Being tested
Central Clock Misalignment, Peripheral Misalignment
Keywords
Sleep, Light Exposure, Metabolism, Circadian Rhythm, Food Intake, Lifestyle Factors, Sleep Hygiene
Medical subject headings
Sleep Hygiene, Sleep Deprivation, Chronobiology Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Central Clock MisalignmentBehavioural

    Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.

  • Peripheral MisalignmentBehavioural

    Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.

Study groups in NCT07329283
Study groupRoleWhat they receive
Sleep Restriction with Central and Peripheral AlignmentNo intervention(Arm "A")-Control condition with central and peripheral aligned circadian rhythms
Sleep Restriction with Central Clock MisalignmentExperimental(Arm "B")-Misalignment of the central clock by nighttime electrical light exposure and dim-light in morning hours.
Receives: Behavioral: Central Clock Misalignment
Sleep Restriction with Peripheral MisalignmentExperimental(Arm "C")-Misalignment of peripheral oscillators by shifting the majority of food intake to the nighttime hours.
Receives: Behavioral: Peripheral Misalignment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin Sensitivity

    Insulin sensitivity will be measured by intravenous glucose tolerance tests.

    Measured: Immediately following the 5-day sleep restriction segment

  2. Internal Circadian Misalignment (Uridine and Isobutyryl-L-carnitine)

    Phase angle between DLMO and acrophase of uridine and isobutyryl-L-carnitine during constant routine.

    Measured: During the constant routine, following the 5-day sleep restriction segment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2026
  2. Study start19 Dec 2025
  3. Primary completion31 May 2030 (estimated)
  4. Study completion31 May 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07329283
Sponsor's protocol ID
185590
Acronym
N-Sync
Status last verified
Jan 2026
First submitted
11 Dec 2025
Last updated
22 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Central Clock Misalignment and Peripheral Misalignment in people with Sleep and Metabolism Changes, run by University of Utah at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Victoria Miranda, MS (385-309-0551, SleepStudyParticipant@utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin Sensitivity (time frame: Immediately following the 5-day sleep restriction segment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in